精准制导技术应用于肝脏肿瘤诊断与治疗中国专家共识(2024版)

  • 摘要: 大多数肝脏恶性肿瘤初诊时即处于中晚期,预后不佳。早期诊断和治疗是改善肝脏恶性肿瘤疗效的关键。近年随着肝脏恶性肿瘤治疗方法和理念的不断发展和进步,极大改善了肝脏恶性肿瘤的预后,但是目前外科手术切除仍是肝脏恶性肿瘤治疗的首选方式。精准肝切除是达到最佳手术效果的技术保障,而术前精准评估、术中实时定位病灶和实时引导切除仍是精准切除的重中之重。为提高肝脏恶性肿瘤术前诊断、术中精准切除和术后疗效,中华预防医学会肝胆胰疾病预防与控制专业委员会及中国医疗保健国际交流促进会肝脏肿瘤学分会组织行业领域专家,围绕肝脏肿瘤精准定位和导航的相关要点开展深入讨论并形成《精准制导技术应用于肝脏肿瘤诊断与治疗中国专家共识(2024版)》,以期指导临床实践,推动学科发展。

     

    Abstract: Most patients with liver malignant tumors are diagnosed as in the middle or advanced stages when first diagnosed, while the prognosis is quite poor in these stages. Early diagnosis and treatment are the key to improve the curative effect of liver malignant tumors. Recently, with the sustainable development and progress of the treatment method, the prognosis of liver malignant tumors has been greatly improved. The surgical resection is still the first‑choice in the treatment of liver malignant tumors. Precise hepatectomy is the guarantee to achieve the best surgical results, while precise preoperative assessment, intraoperative real‑time lesion localization and real‑time guidance are the priority to the precise hepatectomy. In order to improve the pre-operative diagnosis, precise intraoperative resection and postoperative curative effect of liver malignant tumors, the Hepatobiliary and Pancreatic Disease Prevention and Control Specialty Society of Chinees Prevention Medicine Association and the Hepato‑Oncology Branch of China International Exchange and Promotive Association for Medical and Healthcare organize experts to conduct in‑depth discussion on the key points of precise localization and navigation of liver tumors and formulated the Chinese Expert Consensus on Precision Guidance Technology in Diagnosis and Treatment of Liver Tumors (2024 Edition), which could guide the clinical practice and promote the development of the subject.

     

/

返回文章
返回